iData Insights

Emesis (Vomiting) - Pipeline Review, H2 2015 Is Released

Press Release   •   Jan 29, 2016 16:37 IST

Emesis (Vomiting) - Pipeline Review, H2 2015 Summary Global Markets Direct s, Emesis (Vomiting) - Pipeline Review, H2 2015, provides an overview of the Emesis (Vomiting)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Emesis (Vomiting), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Emesis (Vomiting) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Emesis (Vomiting) - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Emesis (Vomiting) and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Emesis (Vomiting) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Emesis (Vomiting) pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Emesis (Vomiting) - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Emesis (Vomiting) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Browsewith TOC @

To Get Sample Copy of Report visit @

Table of Contents

Introduction 5

Global Markets Direct Report Coverage 5

Emesis (Vomiting) Overview 6

Therapeutics Development 7

Pipeline Products for Emesis (Vomiting) - Overview 7

Pipeline Products for Emesis (Vomiting) - Comparative Analysis 8

Emesis (Vomiting) - Therapeutics under Development by Companies 9

Emesis (Vomiting) - Therapeutics under Investigation by Universities/Institutes 10

Emesis (Vomiting) - Pipeline Products Glance 11

Clinical Stage Products 11

Early Stage Products 12

Emesis (Vomiting) - Products under Development by Companies 13

Emesis (Vomiting) - Products under Investigation by Universities/Institutes 14

Emesis (Vomiting) - Companies Involved in Therapeutics Development 15

Daewoong Pharmaceutical Co., Ltd. 15

Epiomed Therapeutics, Inc. 16

InteguRx Therapeutics, LLC 17

Emesis (Vomiting) - Therapeutics Assessment 18

Assessment by Monotherapy Products 18

Assessment by Target 19

Assessment by Mechanism of Action 21

Assessment by Route of Administration 23

Assessment by Molecule Type 25

Drug Profiles 27

Antibodies to Target TRIM-21 for Gastrointestinal and Ear Nose Throat Disorders - Drug Profile 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

DWJ-1308 - Drug Profile 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

ETI-385 - Drug Profile 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

granisetron hydrochloride SR - Drug Profile 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

NEO-1940 - Drug Profile 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

ondansetron hydrochloride - Drug Profile 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

Emesis (Vomiting) - Dormant Projects 33

Emesis (Vomiting) - Discontinued Products 34

Appendix 35

Methodology 35

Coverage 35

Secondary Research 35

Primary Research 35

Expert Panel Validation 35

Contact Us 35

Disclaimer 36

Read More

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

iData Insights

Tel: 1-866-237-2965


AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects